Palomino Laboratories Inc.
PALX
$15.32
-$0.08-0.52%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 696.60K | 805.40K | 742.60K | 1.60M | 337.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.37M | 1.24M | 742.60K | 1.60M | 337.40K |
| Operating Income | -1.37M | -1.24M | -742.60K | -1.60M | -337.40K |
| Income Before Tax | -1.37M | -1.24M | -742.60K | -1.82M | 389.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.37M | -1.24M | -742.60K | -1.82M | 389.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.37M | -1.24M | -742.60K | -1.82M | 389.40K |
| EBIT | -1.37M | -1.24M | -742.60K | -1.60M | -337.40K |
| EBITDA | -1.35M | -1.24M | -- | -- | -- |
| EPS Basic | -0.06 | -0.07 | -0.04 | -0.54 | 0.15 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.02 | -0.34 | 0.09 |
| EPS Diluted | -0.06 | -0.07 | -0.04 | -0.54 | 0.15 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.02 | -0.34 | 0.09 |
| Average Basic Shares Outstanding | 21.82M | 18.51M | 18.64M | 3.38M | 2.58M |
| Average Diluted Shares Outstanding | 21.82M | 18.51M | 18.64M | 3.38M | 2.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |